Related Experiment Video
Updated: Oct 28, 2025

Analysis of Learning and Memory Ability in an Alzheimer's Disease Mouse Model using the Morris Water Maze
Published on: October 29, 2019
Intermittent Hypoxia Training Prevents Deficient Learning-Memory Behavior in Mice Modeling Alzheimer's Disease: A
Myoung-Gwi Ryou1, Xiaoan Chen2,3, Ming Cai2,4
1Department of Medical Laboratory Science and Public Health, Tarleton State University, Texas A&M University System, Stephenville, TX, United States.
Intermittent hypoxia training (IHT) improved spatial learning and memory in Alzheimer's disease (AD) mice by increasing neuroprotective factors, despite ongoing amyloid-beta accumulation. This AD treatment shows promise for cognitive function.
Area of Science:
- Neuroscience
- Gerontology
- Pharmacology
Background:
- Alzheimer's disease (AD) is characterized by amyloid-beta (Aβ) accumulation and cognitive decline.
- The efficacy of normobaric intermittent hypoxia training (IHT) after AD onset is not well understood.
Purpose of the Study:
- To investigate if IHT can improve learning-memory behavior in AD mice with existing Aβ accumulation.
- To determine IHT's effect on Aβ levels and neurotrophic factors like erythropoietin and BDNF in the brain.
Main Methods:
- 12-month-old 3xTg-AD mice and wild-type (WT) mice were used.
- AD mice underwent 21 days of IHT (10% O2 cycles) or sham-IHT (room air).
- Spatial learning-memory was assessed using the Morris water maze; Aβ, erythropoietin, and BDNF levels were measured via ELISA and immunoblotting.
Main Results:
- IHT significantly improved spatial learning-memory compared to sham-IHT in AD mice.
- Aβ levels were not significantly altered by IHT in the studied brain regions.
- IHT significantly increased cerebrocortical erythropoietin and BDNF levels.
Conclusions:
- Normobaric IHT can prevent cognitive decline in AD mouse models even after Aβ accumulation begins.
- IHT enhances key neurotrophic factors, suggesting a potential therapeutic mechanism for AD.
- IHT represents a promising non-pharmacological intervention for managing cognitive deficits in Alzheimer's disease.
More Related Videos
03:26Author Spotlight: Improving Anesthesia Protocols for Enhanced Mouse Acupuncture Research
Published on: December 8, 2023
09:45Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke
Published on: March 22, 2016